Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients

Journal of Clinical Microbiology
Pen-Yi LinCheng-Hsun Chiu

Abstract

Chryseobacterium meningosepticum bloodstream infections in 11 nonneonatal patients were reported. More than half of the infections were community acquired. PCR assays indicated that the organisms produced extended-spectrum beta-lactamases as well as metallo-beta-lactamases. Genotyping showed diverse fingerprints among the isolates. Six patients survived without appropriate antibiotic treatment. Host factors are the major determinant of the outcomes of C. meningosepticum infections.

References

Aug 10, 1975·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·M YamakadoK Machii
Apr 1, 1985·The Journal of Antimicrobial Chemotherapy·M O HussonH Leclerc
May 6, 1974·JAMA : the Journal of the American Medical Association·D Teres
Aug 1, 1973·American Journal of Diseases of Children·H B Hawley, D W Gump
Apr 1, 1981·Journal of Clinical Pathology·M L ThongE L Lee
Oct 1, 1996·Journal of Clinical Microbiology·G H MazurekJ T Crawford

❮ Previous
Next ❯

Citations

Aug 18, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S MarakiE Galanakis
Apr 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M-S HsuP-R Hsueh
Jul 21, 2010·Indian Journal of Medical Microbiology·S SoodS Malvankar
Jun 28, 2011·Journal of Laboratory Physicians·Smita SarmaSunil Sharma
Aug 13, 2013·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Emmy Y Li, Vishal Jhanji
Jun 4, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yi-Cheng ChangShan-Min Chang
Sep 27, 2008·Journal of the Chinese Medical Association : JCMA·Shou-Wu LeeBor-Jen Lee
Mar 6, 2009·International Journal of Antimicrobial Agents·Yi-Tsung LinCheng-Yi Liu
Dec 17, 2015·Internal Medicine·Hideharu HagiyaFumio Otsuka
Sep 25, 2007·Diagnostic Microbiology and Infectious Disease·Chen-Hsiang LeeJien-Wei Liu
Sep 25, 2007·Médecine et maladies infectieuses·I ReynaudC Jacquot
Apr 5, 2014·Hemodialysis International·Vanitha GnanasoundranSrinivasa Prasad
Jan 23, 2016·IDCases·Takashi Shinha, Rakesh Ahuja
Nov 26, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kingsley N WeaverSusan I Gerber
Dec 7, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eric J DziubanDavid D Blaney
Jul 7, 2009·Scandinavian Journal of Infectious Diseases·Yi-Tsung LinCheng-Yi Liu
Aug 31, 2019·Microorganisms·Jiun-Nong LinYi-Han Huang
May 16, 2019·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Manoj Kumar SahuSachin Talwar
Dec 26, 2018·The Journal of Critical Care Medicine·Manuela ArbuneVictorita Stefanescu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.